‘Game-changing’ Alzheimer’s drug approved in US – as UK decision looms

A groundbreaking Alzheimer’s drug has been approved in the United States that slows mental decline by up to 60 percent. Donanemab, sold in the US under the brand name Kisunla, is available for patients with early symptoms of the disease. In Alzheimer’s disease, two proteins accumulate that cause brain cells to dieSource: AP The drug … Read more

The WHO warns against counterfeit medicines used to treat diabetes and weight loss

The World Health Organization (WHO) has issued a medical product warning about counterfeit semaglutides, the type of drugs used in some countries to treat type 2 diabetes and obesity. The alert concerns three counterfeit consignments of semaglutide class medicines (of the specific brand Ozempic), which were delivered in October 2023 in Brazil, in October 2023 … Read more